262 related articles for article (PubMed ID: 27272155)
1. High-Throughput 3D Tumor Spheroid Screening Method for Cancer Drug Discovery Using Celigo Image Cytometry.
Kessel S; Cribbes S; Déry O; Kuksin D; Sincoff E; Qiu J; Chan LL
SLAS Technol; 2017 Aug; 22(4):454-465. PubMed ID: 27272155
[TBL] [Abstract][Full Text] [Related]
2. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
3. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
4. Real-Time Apoptosis and Viability High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Qiu J; Chan LL
SLAS Discov; 2018 Feb; 23(2):202-210. PubMed ID: 28915356
[TBL] [Abstract][Full Text] [Related]
5. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL
J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923
[TBL] [Abstract][Full Text] [Related]
6. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
7. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
8. A High-Throughput Image Cytometry Method for the Formation, Morphometric, and Viability Analysis of Drug-Treated Mammospheres.
Kessel SL; Chan LL
SLAS Discov; 2020 Aug; 25(7):723-733. PubMed ID: 32396489
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric Analysis of Oncology Drug Screening with Aqueous Two-Phase Tumor Spheroids.
Shahi Thakuri P; Ham SL; Luker GD; Tavana H
Mol Pharm; 2016 Nov; 13(11):3724-3735. PubMed ID: 27653969
[TBL] [Abstract][Full Text] [Related]
10. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.
Patel NR; Aryasomayajula B; Abouzeid AH; Torchilin VP
Ther Deliv; 2015; 6(4):509-20. PubMed ID: 25996047
[TBL] [Abstract][Full Text] [Related]
12. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
13. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M
PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734
[TBL] [Abstract][Full Text] [Related]
14. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
15. Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy.
Wilson KM; Mathews-Griner LA; Williamson T; Guha R; Chen L; Shinn P; McKnight C; Michael S; Klumpp-Thomas C; Binder ZA; Ferrer M; Gallia GL; Thomas CJ; Riggins GJ
SLAS Technol; 2019 Feb; 24(1):28-40. PubMed ID: 30289729
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
17. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
18. Novel high-throughput cell-based hybridoma screening methodology using the Celigo Image Cytometer.
Zhang H; Chan LL; Rice W; Kassam N; Longhi MS; Zhao H; Robson SC; Gao W; Wu Y
J Immunol Methods; 2017 Aug; 447():23-30. PubMed ID: 28414024
[TBL] [Abstract][Full Text] [Related]
19. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics.
Solomon MA; Lemera J; D'Souza GG
J Liposome Res; 2016 Sep; 26(3):246-60. PubMed ID: 26780923
[TBL] [Abstract][Full Text] [Related]
20. Multiplexed Viability Assays for High-Throughput Screening of Spheroids of Multiple Sizes.
Marimuthu M; Gervais T
Methods Mol Biol; 2023; 2644():435-447. PubMed ID: 37142939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
